Oral squamous cell carcinoma in the background of oral submucous fibrosis

Close metadata

Recommended articles:

Risks and factors of malignant transformation of lichen planus of the oral cavity: results of a 10-year retrospective study. Russian Journal of Operative Surgery and Clinical Anatomy. 2023;(3):53-57

Molecular pathology of genes of epigenetic regulation in epithelial skin tumors. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):141-148

Patient-centered approach to assessing tolerability of antitumor treatment for oral cavity and oropharyngeal cancer. P.A. Herzen Journal of Oncology. 2024;(2):21-26

Oral squamous cell carcinoma (OSCC) in the background of oral submucous fibrosis (OSMF) is one of the most common presentations of oral cancer among Asian population. OSCC arising in the background of OSMF (OSCC with OSMF) has been a topic of interest among researchers recently and a few studies have considered this to be a distinct clinicopathological entity. This systematic review analyses the demographic and clinicopathological variations of OSCC with OSMF from conventional OSCC to evaluate the distinctiveness of OSCC with OSMF. A comprehensive search from PubMed, Google scholar and manual search were carried out and 4 articles were retrieved and analysed systematically. Out of the total 377 OSCC with OSMF cases and 542 conventional OSCC, males were found to be predominantly affected (82.7% and 73.6%). 47% of the OSCC with OSMF cases were well differentiated squamous cell carcinomas as against 33.4% in conventional OSCC. Lymph node metastases were seen predominantly in conventional OSCC (49.1%) than OSCC with OSMF cases (40.7%). OSCC with OSMF were more prevalent in males and showed better tumour differentiation and lesser lymph node metastasis. Even though the present results inculpate OSCC with OSMF as a distinct clinicopathological entity, there is a dire need for thorough investigation.

Keywords:

oral cancer

submucous fibrosis

OSCC

OSMF

squamous cell carcinoma

Authors:

S. Kizhakkoottu

Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University

ORCID: 0000-0002-3543-2968

P. Ramani

Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University

ORCID: 0000-0002-5426-3506

Received:

30.05.2023

Accepted:

18.10.2023

List of references:

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660
WHO. India. Sourse: Globacan 2020. IARC; 2021. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6:126-130. https://doi.org/10.2174/1874210601206010126
Petersen PE. Oral cancer prevention and control — the approach of the World Health Organization. Oral Oncol. 2009;45(4-5):454-460. https://doi.org/10.1016/j.oraloncology.2008.05.023
Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3(10):733-744. https://doi.org/10.1038/nrc1190
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: an updating of lARC monographs vol. 1 to 42. Supplement 7. International Agency for Research on Cancer, Lyon; 1987;440.
Piemonte ED, Lazos J. Evidence for chronic mechanical irritation as a causative factor in oral cancer: application of Bradford Hill criteria. Transl Res Oral Oncol. 2018;3:1-10. https://doi.org/10.1177/2057178X18791034
Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects. 2014;8(1):6-14. https://doi.org/10.5681/joddd.2014.002
Arakeri G, Rai KK, Hunasgi S, Merkx MAW, Gao S, Brennan PA. Oral submucous fibrosis: an update on current theories of pathogenesis. J Oral Pathol Med. 2017;46(6):406-412. https://doi.org/10.1111/jop.12581
Balakrishnan C, Aswath N. Estimation of serum, salivary immunoglobulin G, immunoglobulin A levels and total protein, hemoglobin in smokeless tobacco chewers and oral submucous fibrosis patients. Contemp Clin Dent. 2015;6(suppl 1):S157-S162. https://doi.org/10.4103/0976-237X.166820
Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42(6):561-568. https://doi.org/10.1016/j.oraloncology.2005.08.005
Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985; 13(6):340-341. https://doi.org/10.1111/j.1600-0528.1985.tb00468.x
Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, Chen CH. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14:99. https://doi.org/10.1186/1472-6831-14-99
Chourasia NR, Borle RM, Vastani A. Concomitant association of oral submucous fibrosis and oral squamous cell carcinoma and incidence of malignant transformation of oral submucous fibrosis in a population of Central India: a retrospective study. J Maxillofac Oral Surg. 2015;14(4):902-906. https://doi.org/10.1007/s12663-015-0760-y
Chiba I. Prevention of betel quid chewers’ oral cancer in the Asian-Pacific area. Asian Pac J Cancer Prev. 2001;2:263-269.
Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA, Korde S, Zade P, Bhowate R, Borle R, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46(6):448-453. https://doi.org/10.1111/jop.12553
Patel KR, Rajagopala M, Vaghela DB, Shah A. A pilot study on Ayurvedic management of oral submucous fibrosis. Ayu. 2015; 36(1):34-40. https://doi.org/10.4103/0974-8520.169018
Gunjal S, Pateel DGS, Yang YH, Doss JG, Bilal S, Maling TH, Mehrotra R, Cheong SC, Zain RBM. An overview on betel quid and areca nut practice and control in selected Asian and South East Asian countries. Subst Use Misuse. 2020;55(9):1533-1544. https://doi.org/10.1080/10826084.2019.1657149
Prabhu RV, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S. Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 2014;6(5):e569-e575. https://doi.org/10.4317/jced.51318
Ray JG, Ranganathan K, Chattopadhyay A. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2): 200-209. https://doi.org/10.1016/j.oooo.2015.11.024
Kujan O, Mello FW, Warnakulasuriya S. Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Dis. 2021;27(8):1936-1946. https://doi.org/10.1111/odi.13727
Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV, Pawar P, Datta S. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck. 2013;35(10):1404-1409. https://doi.org/10.1002/hed.23143
Siriwardena BSMS, Jayawardena KLTD, Senarath NH, Tilakaratne WM. An evaluation of clinical and histopathological aspects of patients with oral submucous fibrosis in the background of oral squamous cell carcinoma. Biomed Res Int. 2018;2018:4154165. https://doi.org/10.1155/2018/4154165
Rangaswamy S, Chikkalingaiah RG, Sanjeevarayappa PN, Govindraju P. Carcinoma arising in the background of oral submucous fibrosis. Ann Maxillofac Surg. 2019;9(2):247-252. https://doi.org/10.4103/ams.ams_280_18
Bhola N, Bhutekar U, Jadhav A. A correlation of depth of tumour invasion and pattern of cervical metastasis in Oral Squamous Cell Carcinoma (OSCC) in the background of Oral Submucous fibrosis (OSMF). Sch J Dent Sci. 2017;4(3):144-148. https://doi.org/10.36347/sjds.2017.v04i03.013
Acharya S, Rahman S, Hallikeri K. A retrospective study of clinicopathological features of oral squamous cell carcinoma with and without oral submucous fibrosis. J Oral Maxillofac Pathol. 2019;23(1):162. https://doi.org/10.4103/jomfp.JOMFP_275_17
Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128(3):268-274. https://doi.org/10.1001/archotol.128.3.268
Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KAAS. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol. 2003;39(2):106-114. https://doi.org/10.1016/s1368-8375(02)00026-x
Martin-Granizo R, Rodriguez-Campo F, Naval L, Diaz Gonzalez FJ. Squamous cell carcinoma of the oral cavity in patients younger than 40 years. Otolaryngol Head Neck Surg. 1997;117(3 Pt. 1): 268-275. https://doi.org/10.1016/s0194-5998(97)70185-2
Porter S. Strong association between areca nut use and oral submucous fibrosis. Evid Based Dent. 2006;7(3):79-80. https://doi.org/10.1038/sj.ebd.6400434
Zhou S, Qu X, Yu Z, Zhong L, Ruan M, Ma C, Wang M, Zhang C, Jian X. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(4):575-581. https://doi.org/10.1016/j.tripleo.2009.10.054
Sarode SC, Sarode GS. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses. 2013;81(4):540-543. https://doi.org/10.1016/j.mehy.2013.07.001
Jayasinghe LA, Peiris PM, Tilakaratne WM, Attygalla AM, Jayasinghe RD, Sitheeque MA, Siriwardena BS. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):210-215. https://doi.org/10.1016/j.oooo.2016.06.001
Gadbail AR, Korde S, Chaudhary MS, Sarode SC, Gondivkar SM, Dande R, Tekade SA, Yuwanati M, Hande A, Patil S. Ki67, CD105, and α-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis. Asian Pac J Cancer Prev. 2020;21(7):2067-2074. https://doi.org/10.31557/APJCP.2020.21.7.2067
Alka HH, Prajakta ZR, Minal CS, Madhuri GN, Swati P, Aakruti A. Immunohistochemical analysis of tumor-associated stroma in oral squamous cell carcinoma with and without preexisting oral submucous fibrosis. J Datta Meghe Inst Med Sci Uni. 2017;12(3): 170-176. https://doi.org/10.4103/jdmimsu.jdmimsu_8_17
Quan H, Liu S, Shan Z, Liu Z, Chen T, Hu Y, Yao Z, Fang L. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Arch Oral Biol. 2020;119:104916. https://doi.org/10.1016/j.archoralbio.2020.104916

Close metadata